Choosing the right distributor is one of the most critical decisions for life sciences companies entering or expanding in a … Read More
Category: Life Sciences
Advisory insights and practical strategies for pharmaceutical, biotech, medical device, and medtech companies operating in Japan. Topics include market access, regulatory trends, distributor performance, commercial models, digital transformation, and cross-border leadership.
This section is designed to help life science executives navigate Japan’s complex healthcare landscape with clarity, confidence, and cultural fluency.
Why Good Products Fail in Japan: It’s Not Always the Market
Many global executives are told the same story when sales in Japan disappoint:“Japan is a difficult market.”“Customers here are conservative.”“The … Read More
Why Japanese Distributors Can Be Your Best Ally – If You Manage the Relationship Well
When a company considers entering Japan, one of the first strategic choices is whether to establish a local office or … Read More
AMED and Its Role in Japan’s Pharma Investment
The Japan Agency for Medical Research and Development (AMED) is a government agency established in 2015 to centralize and streamline Japan’s national … Read More
Sakigake Designation: Accelerating Innovation in Japan
In the competitive world of pharmaceutical development, speed to market is crucial, especially when it comes to addressing serious diseases … Read More
Penetrating Japan’s Medical Device Market
Japan’s medical device market is a land of opportunity, offering a unique blend of advanced healthcare infrastructure, a rapidly aging … Read More
Unlocking Japan’s Pharmaceutical Market: A Strategic Guide for Success
Japan stands as a beacon of opportunity for pharmaceutical companies, offering a unique blend of growth potential, innovation, and access … Read More